Durham, NC · Founded 2020 · Privately Held (backing)
Developer of an epigenetic programming platform designed to create new pathways for the treatment of disease. Tune Therapeutics is based in Durham, NC and was founded in 2020. Its last reported valuation was $340 million in Jan 2025. It has raised $222 million.
Last reported valuation
$340.0M
Oct 2026
Priced at
—
Total raised
$222.4M
Last round
—
Cap table — not yet on record
Tune Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tune Therapeutics with a free account
·The complete investor list: 15 names
·Watch Tune Therapeutics: the Monday email on marks, rounds and moves
